Promising New Treatment for Alzheimer’s Disease Licensed By Sanomune Inc.
3/4/2009 10:11:00 AM
BLOOMINGTON, Minn.--(BUSINESS WIRE)--A Canadian bio-technology company, Sanomune Inc., licensed a new treatment method that helps drugs to reach the brain unlike any other treatment for neurological diseases. The treatment method, developed by HealthPartners Research Foundation, is a new therapeutic technology offering hope to the 5.2 million people in the United States living with Alzheimer’s disease and other neurological diseases.
comments powered by